CD5 and B-cell chronic lymphocytic leukemia: Furthermore, Kurec et al. found that CD5-negative CLL patients exhibited a lower hemoglobin level and higher disease stage (Rai’s classification) at diagnosis; they also demonstrated worse OS, with a five-year survival rate of 55% in CD5-negative patients and >90% in CD5-positive patients [45].